Global Beta-Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2028
Market Analysis and Insights: Global Beta-Nicotinamide Mononucleotide (NMN) Market
The global Beta-Nicotinamide Mononucleotide (NMN) market is valued at US$ 256.74 million in 2021. The market size will reach US$ 1075.42 million by the end of 2028, growing at a CAGR of 20.23% during 2022-2028.
Global Beta-Nicotinamide Mononucleotide (NMN) Scope and Segment
Beta-Nicotinamide Mononucleotide (NMN) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Beta-Nicotinamide Mononucleotide (NMN) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.
By Company
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Segment by Type
Content <98%
Content ≥98%
Segment by Application
Health Care Products
Cosmetics
Others
Segment by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
Korea
India
Australia
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Middle East
Africa
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook